TGFB1 and idiopathic pulmonary fibrosis: Mechanistic insights obtained over the past two decades have shifted the understanding of IPF from a purely inflammation‐driven disease to one centered on repetitive alveolar epithelial injury, aberrant repair, and persistent fibroblast–myofibroblast activation driven by profibrotic mediators, most notably TGF‐β [6].